$TMGI
Marquie Group, Inc. Stock $tmgi

$tmgi Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-K Financial Statement

#000168316823006397 Filed on September 13, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2023
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$77.54K	$103.9K	$356.5K
YoY Change			35.76%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$230.00	$230.00	$1.238K
YoY Change	-40.87%		-42.2%
% of Gross Profit
Operating Expenses	$77.54K	$103.9K	$356.5K
YoY Change	-22.01%		35.76%
Operating Profit	-$77.54K		-$356.5K
YoY Change	-22.01%		35.76%
Interest Expense	$112.6K	$435.1K	$375.0K
YoY Change	179.84%		-41.86%
% of Operating Profit
Other Income/Expense, Net	$430.6K		$1.537M
YoY Change	970.25%		-139.88%
Pretax Income	$353.1K	$331.2K	$1.180M
YoY Change	-352.81%		-128.67%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income	0.0%	0.0%	0.0%
Net Earnings	$353.1K	$331.2K	$1.180M
YoY Change	-352.81%		-128.67%
Net Earnings / Revenue
Basic Earnings Per Share	$0.00		$0.00
Diluted Earnings Per Share	$0.00	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	884.3M shares	756.6M shares	528.2M shares
Diluted Shares Outstanding	756.6M shares		528.2M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$120.00	$0.00	$0.00
YoY Change			-100.0%
Cash & Equivalents	$117.00	$0.00	$0.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory	$699.00	$929.00
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$117.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
LONG-TERM ASSETS
Property, Plant & Equipment	$700.00	$930.00	$930.00
YoY Change			-57.14%
Goodwill
YoY Change
Intangibles	$10.37K	$10.37K
YoY Change	0.0%	0.0%
Long-Term Investments	$6.200M	$6.200M	$6.200M
YoY Change
Other Assets	$6.239M	$6.240M
YoY Change		49688.87%
Total Long-Term Assets	$6.239M	$6.240M	$6.240M
YoY Change	51281.96%	49688.87%	49657.1%
TOTAL ASSETS
Total Short-Term Assets	$117.00	$0.00	$0.00
Total Long-Term Assets	$6.239M	$6.240M	$6.240M
Total Assets	$6.239M	$6.240M	$6.240M
YoY Change	51282.92%	48324.84%	48306.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$67.64K	$50.66K	$50.66K
YoY Change	21.16%	43.1%	43.07%
Accrued Expenses	$1.872M	$1.724M	$1.724M
YoY Change			36.78%
Deferred Revenue
YoY Change
Short-Term Debt	$3.581M	$3.556M	$3.556M
YoY Change			128.73%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$6.013M	$6.367M	$6.367M
YoY Change	3.56%	12.33%	12.33%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.013M	$6.367M	$6.367M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$6.013M	$6.367M	$6.367M
YoY Change	3.56%	12.33%	12.33%
SHAREHOLDERS EQUITY
Retained Earnings	-$14.34M	-$14.70M
YoY Change	-10.44%	-7.43%
Common Stock	$75.66K	$75.66K
YoY Change		4567.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$226.1K	-$127.0K	-$127.0K
YoY Change
Total Liabilities & Shareholders Equity	$6.239M	$6.240M	$6.240M
YoY Change	51282.92%	48324.84%	48306.05%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2023
OPERATING ACTIVITIES
Net Income	$353.1K	$331.2K	$1.180M
YoY Change	-352.81%		-128.67%
Depreciation, Depletion And Amortization	$230.00	$230.00	$1.238K
YoY Change	-40.87%		-42.2%
Cash From Operating Activities	-$337.00	-$74.11K	-$133.3K
YoY Change	-98.74%		-30.67%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$5.000K	-$28.25K
YoY Change
Cash From Investing Activities	$0.00	-$5.000K	-$28.25K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$454.00	79.06K	$161.2K
YoY Change	-98.28%		-16.32%
NET CHANGE
Cash From Operating Activities	-$337.00	-74.11K	-$133.3K
Cash From Investing Activities	$0.00	-5.000K	-$28.25K
Cash From Financing Activities	$454.00	79.06K	$161.2K
Net Change In Cash	$117.00	-50.00	-$353.00
YoY Change	-133.14%		-200.0%
FREE CASH FLOW
Cash From Operating Activities	-$337.00	-$74.11K	-$133.3K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001434601
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	TMGI	Round Up Of Shares From Reverse Stock Split RoundUpOfSharesFromReverseStockSplit		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-05-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--05-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-54163
CY2023	dei	Entity Registrant Name EntityRegistrantName	THE MARQUIE GROUP, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	FL
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-2091212
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	7901 4th St. N
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Ste. 4000
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	St. Petersburgh
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33702
CY2023	dei	City Area Code CityAreaCode	800
CY2023	dei	Local Phone Number LocalPhoneNumber	351-3021
CY2023	dei	Security12b Title Security12bTitle	Common stock, $0.001 par value
CY2023	dei	Trading Symbol TradingSymbol	TMGI
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Public Float EntityPublicFloat	884291	usd
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	884291250	shares
CY2023	dei	Auditor Name AuditorName	Gries & Associates, LLC
CY2023	dei	Auditor Location AuditorLocation	Denver, CO
CY2023	dei	Auditor Firm AuditorFirmId	6778
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	353	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	0	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	353	usd
CY2023Q2	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	6200000	usd
CY2022Q2	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	0	usd
CY2023Q2	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties	28247	usd
CY2022Q2	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties	0	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	20719	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	19481	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	929	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	2167	usd
CY2023Q2	us-gaap	Indefinite Lived Trademarks IndefiniteLivedTrademarks	10365	usd
CY2022Q2	us-gaap	Indefinite Lived Trademarks IndefiniteLivedTrademarks	10365	usd
CY2023Q2	us-gaap	Other Assets OtherAssets	6239541	usd
CY2022Q2	us-gaap	Other Assets OtherAssets	12532	usd
CY2023Q2	us-gaap	Assets Assets	6239541	usd
CY2022Q2	us-gaap	Assets Assets	12885	usd
CY2023Q2	us-gaap	Bank Overdrafts BankOverdrafts	46	usd
CY2022Q2	us-gaap	Bank Overdrafts BankOverdrafts	0	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	50664	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	35405	usd
CY2023Q2	us-gaap	Interest Payable Current InterestPayableCurrent	578017	usd
CY2022Q2	us-gaap	Interest Payable Current InterestPayableCurrent	334180	usd
CY2023Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1145917	usd
CY2022Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	926217	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	66794	usd
CY2022Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	6889	usd
CY2023Q2	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	1465138	usd
CY2022Q2	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	1419108	usd
CY2023Q2	TMGI	Notes Payable To Related Parties Current NotesPayableToRelatedPartiesCurrent	2090772	usd
CY2022Q2	TMGI	Notes Payable To Related Parties Current NotesPayableToRelatedPartiesCurrent	135551	usd
CY2023Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	1035998	usd
CY2022Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	2817101	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	6366552	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	5667562	usd
CY2023Q2	us-gaap	Liabilities Liabilities	6366552	usd
CY2022Q2	us-gaap	Liabilities Liabilities	5667562	usd
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	200	shares
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	200	shares
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	200	shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	200	shares
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000000	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	756612000	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	756612000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16189732	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16189732	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	75663	usd
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	1621	usd
CY2023Q2	TMGI	Common Stock Payable CommonStockPayable	8460	usd
CY2022Q2	TMGI	Common Stock Payable CommonStockPayable	8460	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	14486896	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	10213431	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-14698030	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-15878189	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-127011	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-5654677	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6239541	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12885	usd
CY2023	us-gaap	Revenues Revenues	0	usd
CY2022	us-gaap	Revenues Revenues	0	usd
CY2023	us-gaap	Salaries And Wages SalariesAndWages	240000	usd
CY2022	us-gaap	Salaries And Wages SalariesAndWages	120000	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	85190	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	97162	usd
CY2023	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	31280	usd
CY2022	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	45403	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	356470	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	262565	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-356470	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-262565	usd
CY2023	TMGI	Gain On Settlement Of Debt GainOnSettlementOfDebt	0	usd
CY2022	TMGI	Gain On Settlement Of Debt GainOnSettlementOfDebt	260032	usd
CY2023	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	1911637	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-526690	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	70629	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	361939	usd
CY2023	us-gaap	Interest Expense InterestExpense	375008	usd
CY2022	us-gaap	Interest Expense InterestExpense	645021	usd
CY2023	TMGI	Income Loss On Conversion Of Notes Payable And Accrued Interest IncomeLossOnConversionOfNotesPayableAndAccruedInterest	0	usd
CY2022	TMGI	Income Loss On Conversion Of Notes Payable And Accrued Interest IncomeLossOnConversionOfNotesPayableAndAccruedInterest	-2941708	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1536629	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3853387	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1180159	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4115952	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	1180159	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-4115952	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.25
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.25
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	528202354	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	528202354	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16189732	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16189732	shares
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-4766118	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	3227393	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-4115952	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-5654677	usd
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	147507	usd
CY2023	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	4200000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	1180159	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-127011	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	1180159	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-4115952	usd
CY2023	us-gaap	Depreciation Depreciation	1238	usd
CY2022	us-gaap	Depreciation Depreciation	2142	usd
CY2023	TMGI	Gain Loss On Settlement Of Debt GainLossOnSettlementOfDebt	-0	usd
CY2022	TMGI	Gain Loss On Settlement Of Debt GainLossOnSettlementOfDebt	260032	usd
CY2023	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	1911637	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-526690	usd
CY2023	TMGI	Amortization Of Debt Discounts AmortizationOfDebtDiscounts	70629	usd
CY2022	TMGI	Amortization Of Debt Discounts AmortizationOfDebtDiscounts	361939	usd
CY2023	TMGI	Loss On Conversion Of Notes Payable And Accrued Interest LossOnConversionOfNotesPayableAndAccruedInterest	0	usd
CY2022	TMGI	Loss On Conversion Of Notes Payable And Accrued Interest LossOnConversionOfNotesPayableAndAccruedInterest	2941708	usd
CY2023	TMGI	Default Interest Added To Notes Principal Balance DefaultInterestAddedToNotesPrincipalBalance	0	usd
CY2022	TMGI	Default Interest Added To Notes Principal Balance DefaultInterestAddedToNotesPrincipalBalance	103190	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	15259	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	10311	usd
CY2023	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	291344	usd
CY2022	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	144469	usd
CY2023	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	219700	usd
CY2022	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	93250	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-133308	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-192285	usd
CY2023	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	28247	usd
CY2022	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	-0	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-28247	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2023	us-gaap	Proceeds From Repayments Of Bank Overdrafts ProceedsFromRepaymentsOfBankOverdrafts	46	usd
CY2022	us-gaap	Proceeds From Repayments Of Bank Overdrafts ProceedsFromRepaymentsOfBankOverdrafts	-1140	usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	155935	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	380050	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	-0	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	200500	usd
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	29500	usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	27272	usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	34721	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	41500	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	161202	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	192638	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-353	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	353	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	353	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	353	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023	TMGI	Issuance Of Stock And Promissory Note For Investment In Acquisition IssuanceOfStockAndPromissoryNoteForInvestmentInAcquisition	6200000	usd
CY2022	TMGI	Issuance Of Stock And Promissory Note For Investment In Acquisition IssuanceOfStockAndPromissoryNoteForInvestmentInAcquisition	0	usd
CY2023	TMGI	Initial Derivative Liability Charged To Debt Discounts InitialDerivativeLiabilityChargedToDebtDiscounts	61100	usd
CY2022	TMGI	Initial Derivative Liability Charged To Debt Discounts InitialDerivativeLiabilityChargedToDebtDiscounts	283596	usd
CY2023	TMGI	Conversion Of Debt And Accrued Interest Into Common Stock ConversionOfDebtAndAccruedInterestIntoCommonStock	147507	usd
CY2022	TMGI	Conversion Of Debt And Accrued Interest Into Common Stock ConversionOfDebtAndAccruedInterestIntoCommonStock	285686	usd
CY2022Q2	us-gaap	Stockholders Equity Note Stock Split StockholdersEquityNoteStockSplit	1 share for 1,000 shares reverse stock split
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16189731657	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16189732	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16189732	shares
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_845_eus-gaap--UseOfEstimates_znplfA9MV1f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">c. <span id="xdx_861_zWHO4HBQmGP4">Use of Estimates in the Preparation of Financial Statements</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p>
CY2022	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-864350	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	3750	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	2225	usd
CY2023Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	9842689	usd
CY2023Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration	3340960	usd
CY2023Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration	6521729	usd
CY2023Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1401372	usd
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1262593	usd
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1401372	usd
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1262593	usd
CY2023Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2022Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	247833	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	-401444	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	110605	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Depreciation And Amortization IncomeTaxReconciliationNondeductibleExpenseDepreciationAndAmortization	14832	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Depreciation And Amortization IncomeTaxReconciliationNondeductibleExpenseDepreciationAndAmortization	76007	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	0	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	617759	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	138779	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	59979	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_844_eus-gaap--ConcentrationRiskCreditRisk_zd9Fs1Jcq5ff" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> i. <span id="xdx_86D_z5rY8AhKIfPg">Concentrations of Credit Risk</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risks consist of cash and cash equivalents. The Company places cash and cash equivalents at well-known quality financial institutions. Cash and cash equivalents at banks are insured by the Federal Deposit Insurance Corporation for up to $250,000. The Company did <span id="xdx_90D_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20230531_zkaZCQQkUgji" title="Cash or cash equivalents">no</span>t have any cash or cash equivalents in excess of this amount at May 31, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p>
CY2023Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2023Q2	us-gaap	Excess Of Replacement Or Current Costs Over Stated Lifo Value ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue	250000	usd
CY2023Q2	us-gaap	Inventory Gross InventoryGross	21648	usd
CY2022Q2	us-gaap	Inventory Gross InventoryGross	21648	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	20719	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	19481	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	929	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	2167	usd
CY2023	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	1250	usd
CY2022	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	1250	usd
CY2023	us-gaap	Depreciation Depreciation	1238	usd
CY2022	us-gaap	Depreciation Depreciation	2142	usd
CY2023Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1145917	usd
CY2022Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	926217	usd
CY2022Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	926217	usd
CY2021Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	832967	usd
CY2023	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	240000	usd
CY2022	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	120000	usd
CY2023	TMGI	Payments To Consultants PaymentsToConsultants	-20300	usd
CY2022	TMGI	Payments To Consultants PaymentsToConsultants	-26750	usd
CY2023Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1145917	usd
CY2022Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	926217	usd
CY2023Q2	us-gaap	Notes And Loans Payable NotesAndLoansPayable	1465138	usd
CY2022Q2	us-gaap	Notes And Loans Payable NotesAndLoansPayable	1419108	usd
CY2023Q2	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	1465138	usd
CY2022Q2	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	1419108	usd
CY2023Q2	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	0	usd
CY2022Q2	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	0	usd
CY2023Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	1531932	usd
CY2022Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	1425997	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	-66794	usd
CY2022Q2	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	-6889	usd
CY2023Q2	us-gaap	Notes And Loans Payable NotesAndLoansPayable	1465138	usd
CY2022Q2	us-gaap	Notes And Loans Payable NotesAndLoansPayable	1419108	usd
CY2023Q2	TMGI	Notes Payable Related Parties NotesPayableRelatedParties	2090772	usd
CY2022Q2	TMGI	Notes Payable Related Parties NotesPayableRelatedParties	135551	usd
CY2023Q2	TMGI	Notes Payable To Related Parties Current NotesPayableToRelatedPartiesCurrent	2090772	usd
CY2022Q2	TMGI	Notes Payable To Related Parties Current NotesPayableToRelatedPartiesCurrent	135551	usd
CY2023Q2	TMGI	Notes Payable To Related Parties Noncurrent NotesPayableToRelatedPartiesNoncurrent	0	usd
CY2022Q2	TMGI	Notes Payable To Related Parties Noncurrent NotesPayableToRelatedPartiesNoncurrent	0	usd
CY2023Q2	us-gaap	Derivative Liability Notional Amount DerivativeLiabilityNotionalAmount	703517	usd
CY2023Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1035998	usd
CY2022Q2	us-gaap	Derivative Liability Notional Amount DerivativeLiabilityNotionalAmount	572982	usd
CY2022Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	2817101	usd
CY2023Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	1035998	usd
CY2022Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	2817101	usd
CY2020	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	62458453	shares
CY2020	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	78315	usd
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-159802	usd
CY2020	us-gaap	Equity Fair Value Adjustment EquityFairValueAdjustment	238117	usd
CY2020	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	62458453	shares
CY2020	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	78315	usd
CY2020Q1	us-gaap	Share Price SharePrice	0.0007
CY2021	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	4304842121	shares
CY2021	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	835050	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1445042	usd
CY2022Q2	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1 for 1,000 reverse split
CY2022	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	11511179	shares
CY2022	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	285683	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2941708	usd
CY2022	us-gaap	Equity Fair Value Adjustment EquityFairValueAdjustment	3227391	usd
CY2022	TMGI	Debt Conversion Converted Instrument Shares Issued2 DebtConversionConvertedInstrumentSharesIssued2	11511179	shares
CY2022	TMGI	Debt Conversion Converted Instrument Amount2 DebtConversionConvertedInstrumentAmount2	835050	usd
CY2023	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	73753000	shares
CY2023	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	147507	usd
CY2023Q2	TMGI	Working Capital WorkingCapital	6366552	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-14698030	usd

Files In Submission

Name	View Source	Status
0001683168-23-006397-index-headers.html	Edgar Link	pending
0001683168-23-006397-index.html	Edgar Link	pending
0001683168-23-006397.txt	Edgar Link	pending
0001683168-23-006397-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
marquie_ex2101.htm	Edgar Link	pending
marquie_ex3101.htm	Edgar Link	pending
marquie_ex32.htm	Edgar Link	pending
marquie_i10k-053123.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tmgi-20230531.xsd	Edgar Link	pending
tmgi-20230531_def.xml	Edgar Link	unprocessable
tmgi-20230531_lab.xml	Edgar Link	unprocessable
marquie_i10k-053123_htm.xml	Edgar Link	completed
tmgi-20230531_cal.xml	Edgar Link	unprocessable
tmgi-20230531_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TMGI
Marquie Group, Inc. Stock $tmgi

2023 Q3 Form 10-K Financial Statement

#000168316823006397 Filed on September 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TMGI Marquie Group, Inc. Stock $tmgi

2023 Q3 Form 10-K Financial Statement

#000168316823006397 Filed on September 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TMGI
Marquie Group, Inc. Stock $tmgi